Search Results

Display Settings
Results per page: 10
Sort By: Relevance
Filter
  • 1-10 of  2,565 results for ""TAXANES""

Your Filters

Subject : antineoplastic combined chemotherapy protocols
Reset filters
Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request
Academic Journal

Neoadjuvant inetetamab and pertuzumab with taxanes and carboplatin (TCbIP) In locally advanced HER2-positive breast cancer: a prospective cohort study with propensity-matched analysis.

  • Authors : Jiang M; Department of Medical Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.; Chai Y

Subjects: Breast Neoplasms*/Breast Neoplasms*/Breast Neoplasms*/drug therapy ; Breast Neoplasms*/Breast Neoplasms*/Breast Neoplasms*/pathology ; Breast Neoplasms*/Breast Neoplasms*/Breast Neoplasms*/metabolism

  • Source: BMC cancer [BMC Cancer] 2024 Jul 22; Vol. 24 (1), pp. 877. Date of Electronic Publication: 2024 Jul 22.Publisher: BioMed Central Country of Publication: England NLM ID: 100967800 Publication Model: Electronic Cited Medium: Internet ISSN: 1471-2407

Record details

Read Online Read More Add to Saved list
×
Academic Journal

Comparison of the efficacy of taxanes with carboplatin and anthracyclines with taxanes in neoadjuvant chemotherapy for stage II-III triple negative breast cancer: a retrospective analysis.

  • Authors : Wang H; Harbin Medical University Cancer Hospital, Harbin Medical University, 150 Haping Road, Nangang District, Harbin, 150081, Heilongjiang, China.; Zhang N

Subjects: Triple Negative Breast Neoplasms*/Triple Negative Breast Neoplasms*/Triple Negative Breast Neoplasms*/drug therapy ; Triple Negative Breast Neoplasms*/Triple Negative Breast Neoplasms*/Triple Negative Breast Neoplasms*/pathology ; Carboplatin*/Carboplatin*/Carboplatin*/administration & dosage

  • Source: Journal of cancer research and clinical oncology [J Cancer Res Clin Oncol] 2024 Jun 05; Vol. 150 (6), pp. 291. Date of Electronic Publication: 2024 Jun 05.Publisher: Springer-Verlag Country of Publication: Germany NLM ID: 7902060 Publication Model: Electronic Cited Medium: Internet ISSN: 1432-1335

Record details

Read More Add to Saved list
×
Academic Journal

A Phase II Study of the Efficacy and Safety of Chloroquine in Combination With Taxanes in the Treatment of Patients With Advanced or Metastatic Anthracycline-refractory Breast Cancer.

Subjects: Anthracyclines/Anthracyclines/Anthracyclines/*therapeutic use ; Antibiotics, Antineoplastic/Antibiotics, Antineoplastic/Antibiotics, Antineoplastic/*therapeutic use ; Antineoplastic Combined Chemotherapy Protocols/Antineoplastic Combined Chemotherapy Protocols/Antineoplastic Combined Chemotherapy Protocols/*therapeutic use

  • Source: Clinical breast cancer [Clin Breast Cancer] 2021 Jun; Vol. 21 (3), pp. 199-204. Date of Electronic Publication: 2020 Oct 05.Publisher: Elsevier Country of Publication: United States NLM ID: 100898731 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

Read More Add to Saved list
×
Academic Journal

Relative dose intensity of taxane-based chemotherapy in breast cancer patients in a tertiary hospital.

  • Authors : Helwani AM; Department of Pharmacology & Clinical Pharmacy, College of Medicine and Health Sciences, Sultan Qaboos University, Muscat, Sultanate of Oman.; Al Suleimani YM

Subjects: Breast Neoplasms*/Breast Neoplasms*/Breast Neoplasms*/drug therapy ; Taxoids*/Taxoids*/Taxoids*/administration & dosage ; Taxoids*/Taxoids*/Taxoids*/therapeutic use

  • Source: Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners [J Oncol Pharm Pract] 2024 Dec; Vol. 30 (8), pp. 1364-1371. Publisher: SAGE Publications Country of Publication: England NLM ID: 9511372 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

Read More Add to Saved list
×
Academic Journal

Taxanes for adjuvant treatment of early breast cancer.

  • Authors : Willson ML; Systematic Reviews and Health Technology Assessments, NHMRC Clinical Trials Centre, The University of Sydney, Locked Bag 77, Sydney, NSW, Australia, 1450.; Burke L

Subjects: Antineoplastic Combined Chemotherapy Protocols*; Antineoplastic Agents, Phytogenic/Antineoplastic Agents, Phytogenic/Antineoplastic Agents, Phytogenic/*therapeutic use ; Breast Neoplasms/Breast Neoplasms/Breast Neoplasms/*drug therapy

  • Source: The Cochrane database of systematic reviews [Cochrane Database Syst Rev] 2019 Sep 02; Vol. 9. Cochrane AN: CD004421. Date of Electronic Publication: 2019 Sep 02.Publisher: Wiley Country of Publication: England NLM ID: 100909747 Publication Model: Electronic Cited Medium: Internet ISSN: 1469-493X

Record details

Read More Add to Saved list
×
Academic Journal

Combining CDK4/6 inhibition with taxanes enhances anti-tumor efficacy by sustained impairment of pRB-E2F pathways in squamous cell lung cancer.

  • Authors : Cao J; Oncology Translational Research, Pfizer Inc., San Diego, CA, 92121, USA.; Zhu Z

Subjects: Antineoplastic Combined Chemotherapy Protocols/Antineoplastic Combined Chemotherapy Protocols/Antineoplastic Combined Chemotherapy Protocols/*pharmacology ; Bridged-Ring Compounds/Bridged-Ring Compounds/Bridged-Ring Compounds/*pharmacology ; Carcinoma, Squamous Cell/Carcinoma, Squamous Cell/Carcinoma, Squamous Cell/*drug therapy

  • Source: Oncogene [Oncogene] 2019 May; Vol. 38 (21), pp. 4125-4141. Date of Electronic Publication: 2019 Jan 30.Publisher: Nature Publishing Group Country of Publication: England NLM ID: 8711562 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

Read More Add to Saved list
×
Academic Journal

Addition of taxanes to combination chemotherapy in distal intestinal gastric cancer is more beneficial than proximal ones: A multicenter retrospective study of Turkish Oncology Group.

Subjects: Antineoplastic Combined Chemotherapy Protocols/Antineoplastic Combined Chemotherapy Protocols/Antineoplastic Combined Chemotherapy Protocols/*administration & dosage ; Intestines/Intestines/Intestines/*drug effects ; Stomach Neoplasms/Stomach Neoplasms/Stomach Neoplasms/*drug therapy

  • Source: Journal of B.U.ON. : official journal of the Balkan Union of Oncology [J BUON] 2019 Mar-Apr; Vol. 24 (2), pp. 650-655.Publisher: BAKIS Productions LTD Country of Publication: Cyprus NLM ID: 100883428 Publication Model: Print Cited Medium: Internet ISSN: 2241-6293

Record details

Read More Add to Saved list
×
Academic Journal

A multicenter REtrospective observational study of first-line treatment with PERtuzumab, trastuzumab and taxanes for advanced HER2 positive breast cancer patients. RePer Study.

  • Authors : Gamucci T; a Medical Oncology Unit , ASL Frosinone , Frosinone , Italy.; b Medical Oncology , Sandro Pertini Hospital , Roma , Italy.

Subjects: Antibodies, Monoclonal, Humanized/Antibodies, Monoclonal, Humanized/Antibodies, Monoclonal, Humanized/*therapeutic use ; Antineoplastic Combined Chemotherapy Protocols/Antineoplastic Combined Chemotherapy Protocols/Antineoplastic Combined Chemotherapy Protocols/*therapeutic use ; Breast Neoplasms/Breast Neoplasms/Breast Neoplasms/*drug therapy

  • Source: Cancer biology & therapy [Cancer Biol Ther] 2019; Vol. 20 (2), pp. 192-200. Date of Electronic Publication: 2018 Nov 07.Publisher: Taylor & Francis Country of Publication: United States NLM ID: 101137842 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

Read More Add to Saved list
×
Academic Journal

Collateral resistance to taxanes in enzalutamide-resistant prostate cancer through aberrant androgen receptor and its variants.

  • Authors : Shiota M; Department of Urology, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan.; Dejima T

Subjects: Antineoplastic Combined Chemotherapy Protocols/Antineoplastic Combined Chemotherapy Protocols/Antineoplastic Combined Chemotherapy Protocols/*pharmacology ; Drug Resistance, Neoplasm/Drug Resistance, Neoplasm/Drug Resistance, Neoplasm/*genetics ; Prostatic Neoplasms, Castration-Resistant/Prostatic Neoplasms, Castration-Resistant/Prostatic Neoplasms, Castration-Resistant/*drug therapy

  • Source: Cancer science [Cancer Sci] 2018 Oct; Vol. 109 (10), pp. 3224-3234. Date of Electronic Publication: 2018 Aug 28.Publisher: Wiley Publishing on behalf of the Japanese Cancer Association Country of Publication: England NLM ID: 101168776 Publication Model: Print-Electronic

Record details

Read More Add to Saved list
×
Academic Journal

Comparison of pigmentary side effects of taxanes and anthracyclines: an onychoscopic evaluation.

Subjects: Anthracyclines/Anthracyclines/Anthracyclines/*adverse effects ; Antineoplastic Agents/Antineoplastic Agents/Antineoplastic Agents/*adverse effects ; Antineoplastic Combined Chemotherapy Protocols/Antineoplastic Combined Chemotherapy Protocols/Antineoplastic Combined Chemotherapy Protocols/*adverse effects

  • Source: Cutaneous and ocular toxicology [Cutan Ocul Toxicol] 2017 Jun; Vol. 36 (2), pp. 135-139. Date of Electronic Publication: 2016 May 10.Publisher: Informa Healthcare Country of Publication: England NLM ID: 101266892 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

Read More Add to Saved list
×
  • 1-10 of  2,565 results for ""TAXANES""